Tumor markers of head and neck carcinoma.
Evaluation of the various tumor markers that have been studied in patients with SCC of the head and neck reveals no single marker or battery of markers that is sufficiently specific or sensitive to provide useful clinical data in the treatment of patients with these cancers. This finding reinforces previous investigative and clinical impressions that would suggest that carcinoma of the head and neck is a heterogeneous entity. These tumor marker studies provide additional support for the hypothesis that although various carcinomas of the head and neck may appear identical microscopically, their behavior both clinically and biochemically is nevertheless heterogeneous. Due to the wide variability of the behavior of these tumors, the search for the perfect tumor marker continues. The development of additional multiple-marker batteries may provide the closest approximation to a perfect marker that is feasible. Additional studies into the nature and function of oncogenes may provide additional clues to the variability of these tumors and the resultant heterogenicity of their marker expression.
Eibling
D E
DE
U.S. Air Force Medical Center, Lackland Air Force Base, Texas.
Wagner
R L
RL
Johnson
J T
JT
D000914:Antibodies, Viral / Q000032:analysis; D000951:Antigens, Neoplasm / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood*; D006258:Head and Neck Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000628:therapy; D006728:Hormones / Q000097:blood; D006801:Humans; D008055:Lipids / Q000097:blood; D009092:Mucous Membrane / Q000737:chemistry; D009363:Neoplasm Proteins / Q000097:blood; D009858:Oncogenic Viruses / Q000276:immunology; D011237:Predictive Value of Tests
D000914:Antibodies, Viral; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D006728:Hormones; D008055:Lipids; D009363:Neoplasm Proteins